New modular shoulder implant aims to improve outcomes in tough revision surgeries
NCT ID NCT03270982
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 41 times
Summary
This study is testing a new modular shoulder replacement system in 105 people who need complex revision surgery due to joint disease, trauma, or cancer. The device can replace part or all of the upper arm bone. Researchers are tracking how long the implant lasts and how well patients can use their arm afterward.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ONCOLOGY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Orthopedic Surgery, Rigshospitalet University of Copenhagen
Copenhagen, Denmark
-
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H-1796, Canada
-
Royal Gwent Hospital
Newport, Wales, NP20 2UB, United Kingdom
-
Royal Liverpool University Hospital
Liverpool, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Comprehensive Segmental Revision System (a modular shoulder replacement device)
What this could lead to
If successful, this device could provide a more durable and functional option for people needing complex shoulder revision surgery.
What could go wrong
This is an early-stage study with only 105 participants, so results may not apply to everyone. Device failure or complications like infection are possible risks.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.